木瓜直播

Three U.S. health surveys indicated from 2011 to 2022. (JAMA Network Open)

The FDA is reviewing whether -- billed as a nonaddictive opioid alternative -- should be approved for acute pain. (Washington Post)

increased 82% from 2015 to 2019 and by 40% from 2021 to 2022, according to National Survey on Drug Use and Health data. (Journal of Affective Disorders)

Many if they suspect their patient has an eating disorder. (STAT)

A meta-analysis showed that the at time of diagnosis ranged from 5.7 years at age 65 to 2.2 years at age 85 in men, and from 8 to 4.5 years, respectively, in women. (The BMJ)

are facing increased risks for anxiety, depression, and post-traumatic stress disorder. (ABC News)

A Biden appointee at the VA who advocates wants to join forces with Robert F. Kennedy Jr. (Politico)

A flopped for improving distress, depressive, and anxiety symptoms in a randomized trial in Hong Kong, but did help reduce general stress. (JAMA Network Open)

Overdose death rates in the U.S. -- by a substantial margin -- than in other countries, according to a report from the Commonwealth Fund.

Johnson & Johnson is set to acquire Intra-Cellular Therapies, developer of the (Caplyta), for $14.6 billion. (BioPharma Dive)

Peter Fenwick, MD, a neuropsychiatrist who was an , died last year at age 89. (New York Times)

The the Substance Use and Mental Health Services Administration for boosting the incentives to those battling substance use disorders.

Comment